Marianne P. Allen

Array ( [id] => 4243204 [patent_doc_number] => RE037224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant' [patent_app_type] => 2 [patent_app_number] => 9/156159 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4653 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037224.pdf [firstpage_image] =>[orig_patent_app_number] => 156159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494456 [patent_doc_number] => 06403325 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Methods and compounds for treating alzheimer\'s disease' [patent_app_type] => B1 [patent_app_number] => 09/107112 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6743 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403325.pdf [firstpage_image] =>[orig_patent_app_number] => 09107112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882452 [patent_doc_number] => 20010048924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'METHOD FOR INHIBITING CEREBRAL TISSUE FACTOR MEDIATED REPERFUSION DAMAGE' [patent_app_type] => new [patent_app_number] => 09/103067 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11103 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20010048924.pdf [firstpage_image] =>[orig_patent_app_number] => 09103067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1309863 [patent_doc_number] => 06610293 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria' [patent_app_type] => B1 [patent_app_number] => 09/097055 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20264 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610293.pdf [firstpage_image] =>[orig_patent_app_number] => 09097055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586954 [patent_doc_number] => 06359112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-19 [patent_title] => 'Peptides used as agonists and/or inhibitors of amyloid formation and cytotoxicity and also for use in alzheimer\'s disease, in type II diabetes mellitus and in spongiform encephalophathies' [patent_app_type] => B2 [patent_app_number] => 09/097194 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2866 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359112.pdf [firstpage_image] =>[orig_patent_app_number] => 09097194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216106 [patent_doc_number] => 06110893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Fibroblast growth factor 11' [patent_app_type] => 1 [patent_app_number] => 9/093585 [patent_app_country] => US [patent_app_date] => 1998-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 2 [patent_no_of_words] => 17047 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110893.pdf [firstpage_image] =>[orig_patent_app_number] => 093585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4123443 [patent_doc_number] => 06127131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'DNA encoding a glycine transporter and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/084813 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 10 [patent_no_of_words] => 21270 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127131.pdf [firstpage_image] =>[orig_patent_app_number] => 084813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645602 [patent_doc_number] => 06472367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Compounds and methods for modulating OB-cadherin mediated cell adhesion' [patent_app_type] => B1 [patent_app_number] => 09/073040 [patent_app_country] => US [patent_app_date] => 1998-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 18927 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472367.pdf [firstpage_image] =>[orig_patent_app_number] => 09073040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320778 [patent_doc_number] => 06331401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Uses of the 5-HT4 receptor' [patent_app_type] => 1 [patent_app_number] => 9/328314 [patent_app_country] => US [patent_app_date] => 1998-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 27967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331401.pdf [firstpage_image] =>[orig_patent_app_number] => 328314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311561 [patent_doc_number] => 06242251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Rhesus neuropeptide Y5 receptor' [patent_app_type] => 1 [patent_app_number] => 9/040958 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17959 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242251.pdf [firstpage_image] =>[orig_patent_app_number] => 040958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380065 [patent_doc_number] => 06294355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Synaptic activation protein compositions and method' [patent_app_type] => 1 [patent_app_number] => 9/042428 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 35 [patent_no_of_words] => 12389 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294355.pdf [firstpage_image] =>[orig_patent_app_number] => 042428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4281906 [patent_doc_number] => 06267955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Mononuclear phagocytes and their use to promote axonal regeneration' [patent_app_type] => 1 [patent_app_number] => 9/041280 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 12353 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/267/06267955.pdf [firstpage_image] =>[orig_patent_app_number] => 041280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446394 [patent_doc_number] => 06368822 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Fibroblast growth factor 13' [patent_app_type] => B1 [patent_app_number] => 09/036985 [patent_app_country] => US [patent_app_date] => 1998-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12516 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368822.pdf [firstpage_image] =>[orig_patent_app_number] => 09036985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256549 [patent_doc_number] => 06204010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Flea protease proteins, nucleic acid molecules, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/032215 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17882 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204010.pdf [firstpage_image] =>[orig_patent_app_number] => 032215 [rel_patent_id] =>[rel_patent_doc_number] =>)